Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/ijms22073676
Keywords
pentacyclic triterpenes; betulonic acid derivatives; natural compounds; proliferation; apoptosis; in vitro; in vivo; cancer
Funding
- Internal grant at Victor Babes University of Medicine and Pharmacy [1EXP/1233/30.01.2020 LUPSKINPATH]
- ERA.Net RUS Plus project [RUS_ST2017-139]
Ask authors/readers for more resources
Clinical trials have shown that natural compounds can be effective in managing cancer, serving as starting points for new drug development. Betulonic acid and its derivatives have potential as anticancer agents, but more research is needed to fully understand their mechanisms and efficacy.
Clinical trials have evidenced that several natural compounds, belonging to the phytochemical classes of alkaloids, terpenes, phenols and flavonoids, are effective for the management of various types of cancer. Latest research has proven that natural products and their semisynthetic variants may serve as a starting point for new drug candidates with a diversity of biological and pharmacological activities, designed to improve bioavailability, overcome cellular resistance, and enhance therapeutic efficacy. This review was designed to bring an update regarding the anticancer potential of betulonic acid and its semisynthetic derivatives. Chemical derivative structures of betulonic acid including amide, thiol, and piperidine groups, exert an amplification of the in vitro anticancer potential of betulonic acid. With the need for more mechanistic and in vivo data, some derivatives of betulonic acids may represent promising anticancer agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available